胆道癌的外科和息系统治疗
Hossein Taghizadeh1,2,3,4,5, Yawen Dong6, Thomas Gruenberger6
1Division of Oncology, Department of Internal Medicine I, University Hospital St. Pölten, St. Pölten, Austria.
Therapeutic advances in medical oncology
|April 1, 2024
概括
胆道癌 (BTC) 由于诊断迟到,往往预后不好. 系统治疗的进步,包括化疗,向治疗和免疫治疗,为BTC患者提供了更好的结果.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 手术瘤学手术瘤学
背景情况:
- 胆道癌 (BTC) 由于晚期诊断和侵袭性生物学,导致预后不佳,因此具有重大挑战.
- 最近在诊断,手术技术和分子分析方面的进展正在改善BTC患者的治疗结果.
- 新辅助疗法在改善BTC手术结果中的作用正在调查中,已确定局部晚期疾病的征兆.
研究的目的:
- 为提供对胆道癌症的新辅助和息系统治疗策略的全面审查.
- 探索新的系统性治疗概念及其对BTC预后的潜在影响.
- 讨论当前的证据和未来的系统疗法在管理BTC的方向.
主要方法:
- 关于胆道癌症的诊断和治疗近期进展的文献综述.
- 系统治疗方法的分析,包括化疗,向治疗和免疫治疗.
- 评估新辅助疗法在可切除和局部发达BTC中的作用.
主要成果:
- 组合化疗方案是高级,未经治疗的BTC的标准.
- 分子分析揭示了生物治疗的可操作目标,可能改善预后.
- 除了化疗外,免疫疗法也可能使BTC患者的一个子集受益.
结论:
- 系统疗法,包括化疗,向治疗和免疫疗法,对于治疗胆道癌症至关重要.
- 新辅助疗法的作用正在不断发展,特别是在局部晚期和精选的切除病例中.
- 基于分子分析的个性化治疗策略有望改善BTC患者的治疗结果.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Endoscopic Procedures V: ERCP
210
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
210
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127


